









시장가
/
주식
/
nasdaq-gild
/

Gilead Sciences Inc

GILD

124.700USD

-0.970-0.77%

종가 12/26, 16:00（ET）시세는 15분 지연됩니다

154.88B시가총액

19.15P/E TTM



Gilead Sciences Inc

124.700

-0.970-0.77%

개요 회사 금융 분석

개요

회사

금융

분석

자세한 내용은 Gilead Sciences Inc 회사

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. It also develops the HB-400 program and the HB-500 program. It develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. It operates in more than 35 countries worldwide.

Gilead Sciences Inc 정보



종목 코드 GILD

회사 이름Gilead Sciences Inc

상장일Jan 22, 1992

CEOO'Day (Daniel P)

직원 수17600

유형Ordinary Share

회계 연도 종료Jan 22

주소333 Lakeside Dr

도시FOSTER CITY

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호94404-1147

전화16505743000

웹사이트https://www.gilead.com/

종목 코드 GILD

상장일Jan 22, 1992

CEOO'Day (Daniel P)

Gilead Sciences Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Ms. Johanna Mercier

Chief Commercial Officer

79.97K

-3.62%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+6.18%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+14.82%

Ms. Kelly A. Kramer

Independent Director

1.34K

Ms. Erin Burkhart

Senior Vice President, Principal Accounting Officer, Controller

Dr. Dietmar P. Berger, M.D., Ph.D.

Chief Medical Officer

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

Mr. Harish Manwani

Independent Director

Dr. Ted W. Love, M.D.

Independent Director

Mr. Javier J. Rodriguez

Independent Director

이름

이름/직위

직위

주식 보유

변동

Ms. Johanna Mercier

Chief Commercial Officer

79.97K

-3.62%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+6.18%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+14.82%

Ms. Kelly A. Kramer

Independent Director

1.34K

Ms. Erin Burkhart

Senior Vice President, Principal Accounting Officer, Controller

Dr. Dietmar P. Berger, M.D., Ph.D.

Chief Medical Officer

수익 분석

통화: USD마지막 업데이트: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

사업별USD

이름

수익

비율

Biktarvy

3.53B

49.84%

Descovy

653.00M

9.22%

Yescarta

393.00M

5.55%

Genvoya

378.00M

5.34%

Trodelvy

364.00M

5.14%

기타

1.76B

24.91%

지역별USD

이름

수익

비율

United States

5.00B

70.59%

Europe

1.17B

16.51%

Other Locations

792.00M

11.18%

사업별

지역별

사업별USD

이름

수익

비율

Biktarvy

3.53B

49.84%

Descovy

653.00M

9.22%

Yescarta

393.00M

5.55%

Genvoya

378.00M

5.34%

Trodelvy

364.00M

5.14%

기타

1.76B

24.91%

주식 보유 통계

마지막 업데이트: Sun, Nov 16

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

9.54%

BlackRock Institutional Trust Company, N.A.

5.86%

State Street Investment Management (US)

4.76%

Fidelity Management & Research Company LLC

4.34%

Capital World Investors

3.64%

기타

71.86%

주주

비율

The Vanguard Group, Inc.

9.54%

BlackRock Institutional Trust Company, N.A.

5.86%

State Street Investment Management (US)

4.76%

Fidelity Management & Research Company LLC

4.34%

Capital World Investors

3.64%

기타

71.86%

주주 유형

주주

비율

Investment Advisor

54.42%

Investment Advisor/Hedge Fund

25.61%

Pension Fund

2.86%

Research Firm

2.81%

Hedge Fund

2.00%

Bank and Trust

1.90%

Sovereign Wealth Fund

1.73%

Insurance Company

0.15%

Venture Capital

0.10%

기타

8.41%

기관 주식 보유



마지막 업데이트: Wed, Oct 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q3

3433

1.13B

91.16%

+23.58K

2025Q2

3388

1.12B

90.01%

-12.02M

2025Q1

3442

1.12B

90.14%

-10.49M

2024Q4

3313

1.12B

90.13%

+4.63M

2024Q3

3207

1.10B

88.48%

-11.56M

2024Q2

3188

1.10B

88.24%

-14.37M

2024Q1

3196

1.10B

88.13%

-22.04M

2023Q4

3252

1.11B

88.75%

-8.79M

2023Q3

3190

1.10B

88.14%

-23.58M

2023Q2

3196

1.10B

88.02%

-11.22M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

118.78M

9.57%

+1.87M

+1.60%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

70.80M

5.71%

+138.89K

+0.20%

Jun 30, 2025

State Street Investment Management (US)

59.19M

4.77%

-335.51K

-0.56%

Jun 30, 2025

Fidelity Management & Research Company LLC

53.76M

4.33%

+2.55M

+4.98%

Jun 30, 2025

Capital World Investors

46.30M

3.73%

-7.24M

-13.53%

Jun 30, 2025

Dodge & Cox

30.82M

2.48%

-1.88M

-5.74%

Jun 30, 2025

Capital Research Global Investors

31.10M

2.51%

-23.51M

-43.06%

Jun 30, 2025

Geode Capital Management, L.L.C.

29.21M

2.35%

+727.51K

+2.55%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

25.46M

2.05%

-89.95K

-0.35%

Aug 31, 2025

Wellington Management Company, LLP

37.53M

3.02%

+10.17M

+37.18%

Jun 30, 2025

주식 배당금



지난 5년 동안 총 18.49B USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Oct 30, 2025

GILD.NB Final Cash Dividend of gross USD 0.79 paid on Dec 30, 2025 going ex on Dec 15, 2025

Dec 15, 2025

Dec 30, 2025

Dec 15, 2025

Aug 07, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Sep 29, 2025 going ex on Sep 15, 2025

Sep 15, 2025

Sep 29, 2025

Sep 15, 2025

Apr 24, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Jun 27, 2025 going ex on Jun 13, 2025

Jun 13, 2025

Jun 27, 2025

Jun 13, 2025

Feb 11, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Mar 28, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Mar 28, 2025

Mar 14, 2025

Nov 12, 2024

GILD.NB Final Cash Dividend of gross USD 0.77 paid on Dec 30, 2024 going ex on Dec 13, 2024

Dec 13, 2024

Dec 30, 2024

Dec 13, 2024

Aug 13, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Sep 27, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Sep 27, 2024

Sep 13, 2024

Apr 26, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Jun 27, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jun 27, 2024

Jun 14, 2024

Feb 06, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Mar 28, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Mar 28, 2024

Mar 14, 2024

Nov 08, 2023

GILD.NB Final Cash Dividend of gross USD 0.75 paid on Dec 28, 2023 going ex on Dec 14, 2023

Dec 15, 2023

Dec 28, 2023

Dec 14, 2023

Aug 07, 2023

GILD.NB Interim Cash Dividend of gross USD 0.75 paid on Sep 28, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Sep 28, 2023

Sep 14, 2023

주식 분할



날짜

유형

비율

데이터 없음

날짜

유형

비율

데이터 없음

자주 묻는 질문

Gilead Sciences Inc의 상위 5대 주주는 누구인가요?



Gilead Sciences Inc의 상위 5대 주주는 다음과 같습니다:
The Vanguard Group, Inc.는 118.78M주의 주식을 보유하고 있으며, 전체 주식의 9.57%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 70.80M주의 주식을 보유하고 있으며, 전체 주식의 5.71%를 차지합니다.
State Street Investment Management (US)는 59.19M주의 주식을 보유하고 있으며, 전체 주식의 4.77%를 차지합니다.
Fidelity Management & Research Company LLC는 53.76M주의 주식을 보유하고 있으며, 전체 주식의 4.33%를 차지합니다.
Capital World Investors는 46.30M주의 주식을 보유하고 있으며, 전체 주식의 3.73%를 차지합니다.

Gilead Sciences Inc의 상위 3대 주주 유형은 무엇인가요?



Gilead Sciences Inc의 주요 주주 유형 상위 3가지는
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.